SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Andreas Helke who wrote (20013)5/4/1998 1:16:00 PM
From: Hippieslayer  Respond to of 32384
 
the action of ENMD based on rats should definitely be a clue as to how lgnd will react if Targretin is as effective in breast cancer in women as it was in rats. We are in agreement on that.



To: Andreas Helke who wrote (20013)5/4/1998 10:47:00 PM
From: John O'Neill  Read Replies (1) | Respond to of 32384
 
How about Lymphoma, etc. cutting off blood supply may not work here.

JO